注射用血凝酶与西咪替丁联合治疗新生儿上消化道出血的临床价值评价

Clinical Value of Combined Hemocoagulase With Cimetidine in the Treatment of Neonatal Upper Gastrointestinal Hemorrhage

目的探究注射用血凝酶(巴曲亭)与西咪替丁联合治疗新生儿上消化道出血的临床价值。方法随机选取我院收治的90例足月新生儿作为研究对象,随机将其分为实验组和对照组,每组患者45例。对照组使用常规的药物进行治疗,实验组患者在常规治疗的基础之上使用巴曲亭与西咪替丁联合治疗。结果实验组患者的治疗有效率为95.6%,对照组患者的治疗有效率为84.4%,实验组患者的治疗有效率明显高于对照组。结论对于上消化道出血的新生儿治疗来说,在常规治疗的基础上使用巴曲亭与西咪替丁联合治疗,能够取得更好的治疗效果,对新生儿的治疗有非常重要的临床意义。

Objective To investigate the clinical value of combined hemocoagulase with cimetidine in the treatment of neonatal upper gastrointestinal bleeding.Methods A total of90full-term neonates were selected as the subjects in our hospital.They were randomly divided into the experimental group and the control group,with45patients in each group.The control group was treated with conventional drugs,and the patients in the experimental group were treated with hemocoagulase and cimetidine on the basis of conventional treatment.Results The effective rate of treatment was95.6%in the experimental group and84.4%in the control group.The effective rate of the experimental group was higher than that of the control group.Conclusion For the treatment of neonatal upper gastrointestinal hemorrhage,the use of hemocoagulase and cimetidine on the basis of routine treatment,can achieve better treatment effect,has very important clinical significance in treatment of newborn.